The content discusses the ongoing shortage of Becton Dickinson BACTEC blood culture bottles in the United States, which is expected to last at least until September. This shortage is critical as most blood cultures in the US are performed using continuous-monitoring blood culture systems, and the Becton Dickinson system is used in about half of all US laboratories.
The shortage could lead to delays in diagnosis, misdiagnosis, and other challenges in the management of patients with infectious diseases. Healthcare providers, laboratories, and health departments are urged to take immediate action to mitigate the potential impact of the shortage. This includes determining the type of blood culture bottles they have, optimizing the use of blood cultures, taking steps to prevent contamination, ensuring appropriate blood volume collection, and assessing alternate options for blood cultures.
Health departments are advised to contact hospitals and laboratories in their jurisdictions to determine the extent of the shortage and educate others on the supply shortage, optimal use of blood cultures, and mechanisms for reporting supply chain issues to the FDA. The CDC, in collaboration with the Infectious Diseases Society of America, has also hosted a webinar to share strategies for coping with the shortage and protecting patients.
The shortage is attributed to reduced availability of plastic bottles from Becton Dickinson's supplier, which the company says is a more complex issue than originally communicated. The FDA has acknowledged the supply disruptions and recommended strategies to preserve the supply for patients at highest risk.
To Another Language
from source content
www.medscape.com
Principais Insights Extraídos De
by Marilynn Lar... às www.medscape.com 07-30-2024
https://www.medscape.com/viewarticle/blood-bottle-shortage-could-disrupt-patient-care-2024a1000dx3Perguntas Mais Profundas